Fasamx

Were you looking for information about Fosamax? Fasamx is a common misspelling of Fosamax.

Fosamax^® (alendronate sodium) is a medication used to treat osteoporosis and Paget's disease. The drug has been evaluated in four studies of postmenopausal women with osteoporosis. In these studies, the drug reduced the risk of vertebral fractures (broken spinal bones) by 48 percent. In women who already had a vertebral fracture before starting Fosamax, the drug reduced the risk of a broken hip or wrist by about 50 percent. The studies also showed that Fosamax increased bone mineral density (a measure of the strength of bones) in the spine and hip. Interestingly, women taking Fosamax lost less height, compared with women not taking it.

(To read the full eMedTV article on this topic, click Fosamax. This article takes an in-depth look at this drug, including its possible side effects, dosing guidelines, and other conditions it is licensed to treat.)